.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Bitte aktivieren Sie Javascript um alle Funktionen nutzen zu können und ihre Nutzererfahrung zu verbessern.

Dr. Juan José Segura-Sampedro

Madrid / ES

Hospital Universitario La Paz

Einsätze

08.11.2024

09:00 – 09:20 15 Min. 5 Min.
Invited Talk
IT-08
State-of-the-Art in Intraperitoneal Hyperthermia: Current Indications and Evolving Controversies
09:52 – 09:54 2 Min. 0 Min.
Flash Presentation
FP-35
Development of an anticancer tissue adhesive for intraperitoneal chemotherapy as an adjuvant to HIPEC
HIPEC
09:54 – 09:56 2 Min. 0 Min.
Flash Presentation
FP-36
Establishment of a murine model of localised advanced ovarian cancer to test this novel intraperitoneal drug delivery system
Emerging topics